(Q35635599)
Statements
The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting (English)
Haya Ascher-Svanum
1 reference
John S Kennedy
David Lee
Merle Haberman
Haya Ascher-Svanum